- Home
- TEVA vs SHG Comparison
TEVA vs SHG Comparison
Compare TEVA & SHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TEVA | SHG |
|---|---|---|
| Founded | 1901 | 1982 |
| Country | Israel | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 26.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TEVA | SHG |
|---|---|---|
| Price | $30.30 | $53.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $29.78 | N/A |
| AVG Volume (30 Days) | ★ 10.6M | 178.4K |
| Earning Date | 01-28-2026 | 10-30-2025 |
| Dividend Yield | N/A | ★ 2.32% |
| EPS Growth | N/A | ★ 9.37 |
| EPS | 0.62 | ★ 6.76 |
| Revenue | ★ $16,776,000,000.00 | $10,722,437,949.00 |
| Revenue This Year | $4.74 | $6.52 |
| Revenue Next Year | $0.48 | $3.97 |
| P/E Ratio | $48.27 | ★ $7.57 |
| Revenue Growth | 0.02 | ★ 0.61 |
| 52 Week Low | $12.47 | $28.76 |
| 52 Week High | $30.20 | $56.13 |
Technical Indicators
Market Signals| Indicator | TEVA | SHG |
|---|---|---|
| Relative Strength Index (RSI) | 81.00 | 48.80 |
| Support Level | $28.00 | $52.47 |
| Resistance Level | $30.20 | $53.81 |
| Average True Range (ATR) | 0.66 | 0.76 |
| MACD | 0.16 | -0.22 |
| Stochastic Oscillator | 96.20 | 21.42 |
Price Performance
Historical ComparisonAbout TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About SHG Shinhan Financial Group Co Ltd
Shinhan Financial Group Co Ltd is a Korean banking group. Along with its subsidiaries the company provides, comprehensive financial services which consist of commercial banking services, credit card services, securities services, insurance, credit services, and asset management services, including securities investment trust management, investment advisory, call transaction, domestic and foreign private equity fund business, and other services. The majority of the revenue is generated from its Banking business which includes retail, corporate, international, and other banking services the company offers.